Brief: Ryvu Therapeutics Q1 Net Loss Widens To 19.4 Mln Zlotys
May 15 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q1 NET LOSS AT 19.4 MILLION ZLOTYS VERSUS LOSS OF 17.6
MILLION
ZLOTYS YEAR AGO
* Q1 OPERATING REVENUE AT 25.4 MILLION ZLOTYS VERSUS 18.3
MILLION
ZLOTYS YEAR AGO
* Q1 OPERATING LOSS AT 22.5 MILLION ZLOTYS VERSUS LOSS OF
18.1
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM767HP0a
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys